Company Synvista Therapeutics, Inc. Nasdaq
Equities
SYNI
US87164M1009
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 30/06/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 30/06/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 10,000,000 | 0 | 0 | 15.89 % |
Stock B | 1 | 2,586,326 | 2,000,000 ( 77.33 %) | 0 |
Company contact information
Synvista Therapeutics, Inc.
6 Campus Drive
07054, Parsippany
+
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- SYNI Stock
- SYNI Stock
- Company Synvista Therapeutics, Inc.